黑色素缩激素受体的分子特征
Y Saito1, H P Nothacker, Z Wang
1Department of Pharmacology, University of California, Irvine 92697-4625, USA.
Nature
|July 27, 1999
概括
研究人员确定了孤儿G蛋白结合受体 (GPCR) 的天然配体SLC-1,作为黑色素缩激素 (MCH). 这种神经调节食行为并激活SLC-1通路,这表明对食品消费调节的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 孤儿G蛋白结合受体 (GPCRs) 是发现新信号分子的目标.
- GPCRs具有结构上的相似性,但结合了未知的联结体.
- 识别孤儿GPCRs的配体对于理解细胞通信至关重要.
研究的目的:
- 将孤儿GPCR,SLC-1的自然连接体分离和描述.
- 为了研究已识别的联体受体相互作用的功能作用.
- 探索准这种受体系统的潜在治疗应用.
主要方法:
- 从脑部提取物中分离SLC-1连接体.
- 作为连接体的神经胺氨酸度激素 (MCH) 的表征.
- 使用G ((alpha) i和G ((alpha) q蛋白的激活试验.
- 大脑中MCH受体的组织局部化研究.
主要成果:
- 黑色素缩激素 (MCH) 被确定为孤儿GPCR,SLC-1的天然配体.
- 在纳米分子度下,MCH通过G ((alpha) i/G ((alpha) q蛋白激活SLC-1通路.
- 该MCH受体在与嗅觉学习和强化相关的大脑区域表达.
结论:
- MCH-SLC-1系统在调节哺乳动物大脑功能,特别是食行为方面发挥着作用.
- 鉴定的受体局部化表明它在嗅觉学习和奖励机制中起着作用.
- 准MCH受体可能为调节神经元对食物消费的控制提供治疗策略.
相关概念视频
Protein and Protein Structure
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme can...
A protein's shape is critical to its function. For example, an enzyme can...
Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...


